Chen Wang, Ph.D., a University of Oklahoma researcher, has received a fellowship from the Prevent Cancer Foundation to improve kidney cancer diagnostics. Wang's research in the Biophotonic Imaging Laboratory aims to address kidney biopsy imaging issues, reducing failed surgeries and patient complications.
According to OU News, Wang is working on a technique to improve biopsy accuracy using an optical coherence tomography (OCT) probe. Traditional ultrasound often leaves doctors uncertain about the biopsy needle's location, potentially missing small tumors. Wang told OU News, "Navigation to a small tumor, perhaps two or three millimeters in size, might be difficult using traditional imaging methods during biopsy." His OCT probe aims to resolve this issue.
Ultrasound is often inadequate for visualizing the biopsy path, contributing to a 14% failure rate in surgeries, according to a 16-year analysis from a national biopsy laboratory. Wang's OCT probe system could improve detection of blood vessels, reducing bleeding risks, and help doctors identify tumor types.
With kidney cancer rates on the rise, Wang’s research is crucial for faster and more accurate diagnosis. Wang stated these diagnostic improvements are essential for better health results for patients.
As per OU News, the fellowship supports a two-year project called "Early Detection of Renal Cancer by a Novel Imaging Platform," aligning with the Prevent Cancer Foundation's focus on cancer prevention and early detection.
